3,067 Shares in The Cooper Companies, Inc. (NASDAQ:COO) Acquired by Caprock Group LLC

Caprock Group LLC acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 3,067 shares of the medical device company's stock, valued at approximately $282,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in COO. Ashton Thomas Securities LLC bought a new stake in shares of Cooper Companies during the 3rd quarter valued at about $25,000. Covestor Ltd boosted its holdings in shares of Cooper Companies by 144.9% in the third quarter. Covestor Ltd now owns 338 shares of the medical device company's stock worth $37,000 after buying an additional 200 shares during the last quarter. Brown Brothers Harriman & Co. grew its position in Cooper Companies by 191.0% during the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company's stock valued at $46,000 after buying an additional 275 shares during the period. West Financial Advisors LLC bought a new stake in Cooper Companies during the fourth quarter valued at approximately $49,000. Finally, Friedenthal Financial purchased a new stake in Cooper Companies during the third quarter valued at approximately $50,000. Institutional investors own 24.39% of the company's stock.

Cooper Companies Trading Up 0.1 %

NASDAQ:COO traded up $0.06 during mid-day trading on Monday, hitting $93.63. 1,130,056 shares of the stock traded hands, compared to its average volume of 1,297,787. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 52 week low of $84.76 and a 52 week high of $112.38. The stock has a market capitalization of $18.69 billion, a price-to-earnings ratio of 48.02, a PEG ratio of 2.41 and a beta of 1.00. The firm's 50 day moving average is $94.80 and its two-hundred day moving average is $99.86.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $1.03 billion. During the same quarter in the previous year, the business earned $0.87 EPS. Cooper Companies's revenue was up 9.8% compared to the same quarter last year. On average, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Ratings Changes

COO has been the topic of a number of analyst reports. Wells Fargo & Company lifted their price objective on Cooper Companies from $115.00 to $118.00 and gave the company an "overweight" rating in a research report on Friday, December 6th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a report on Friday, December 6th. Citigroup dropped their price target on shares of Cooper Companies from $116.00 to $115.00 and set a "buy" rating for the company in a research report on Friday, December 6th. StockNews.com downgraded shares of Cooper Companies from a "buy" rating to a "hold" rating in a research report on Wednesday, December 11th. Finally, Morgan Stanley dropped their target price on shares of Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a report on Friday, December 6th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.